• SA_member_26922403@example.com
    Delmar Pharmaceutical's is trading at 1/10th the valuation of $NWBO with and $DMPI has 100x better chance of getting FDA approval.
    7/15/14
    Reply (5)
    • jmccormick79: What do you think is holding down $DMPI's valuation? I'm shocked it isn't sitting at $2.50+ per share (minimum) right now.
      7/15/14
    • jmccormick79: What's holding down the valuation of $DMPI?
      7/15/14
    • SA_member_26922403@example.com: Lack of exposure. The volume in their stock is a lot less than $NWBO. If $DMPI has a million shares traded per day stock would be at $2.50.
      7/16/14
    • SA_member_26922403@example.com: I talked to an oncologist in front of the $DMPI poster at ASCO in Chicago this year. He said $DMPI has an exciting drug.
      7/16/14
    • Bill Mullen: Word on the street, DMPI looking to raise 10m asap. "Special through certain brokers" .80 per share, hold for 6 months. Warrants to sweeten deal ?????? anyone
      Apr 23, 1:23 PM